Vivimed Labs posts consolidated loss of Rs. 23.68 crores in Q3 FY22

Vivimed Labs Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 56.1612 crores during the period ended December 31, 2021 as compared to Rs. 54.5179 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. -23.6821 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -23.2992 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. -2.77 for the period ended December 31, 2021 as compared to Rs. -2.73 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 56.1612 crs	₹54.5179 crs	3.01%
Net Profit	₹-23.6821 crs	₹-23.2992 crs	1.64%
EPS	₹-2.77	₹-2.73	1.47%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 56.1612 crores during the period ended December 31, 2021 as compared to Rs.282.2858 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-23.6821 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-49.5490 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.-2.77 for the period ended December 31, 2021 as compared to Rs.-5.80 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 56.1612 crs	₹282.2858 crs	-80.10%
Net Profit	₹-23.6821 crs	₹-49.5490 crs	52.20%
EPS	₹-2.77	₹-5.80	52.24%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.176.8540 crores during the 9 Months period ended December 31, 2021 as compared to Rs.830.5153 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-49.3167 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-50.3311 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.-5.77 for the 9 Months period ended December 31, 2021 as compared to Rs.-5.89 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹176.8540 crs	₹830.5153 crs	-78.71%
Net Profit	₹-49.3167 crs	₹-50.3311 crs	2.02%
EPS	₹-5.77	₹-5.89	2.04%

Shares of Vivimed Labs Limited was last trading in BSE at Rs. 19.35 as compared to the previous close of Rs. 19.90. The total number of shares traded during the day was 126711 in over 796 trades.

The stock hit an intraday high of Rs. 19.75 and intraday low of 18.50. The net turnover during the day was Rs. 2424522.00.

Source : Equity Bulls

Keywords

VivimedLabs Q3FY22 9MFY22 ResultUpdate